Density of the Notch ligand Delta1 determines generation of B and T cell precursors from hematopoietic stem cells by Dallas, Mari H. et al.
T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
JEM © The Rockefeller University Press $8.00
Vol. 201, No. 9, May 2, 2005 1361–1366 www.jem.org/cgi/doi/10.1084/jem.20042450
 
BRIEF DEFINITIVE REPORT
 
1361
 
Density of the Notch ligand Delta1 
determines generation of B and T cell 
precursors from hematopoietic stem cells
 
Mari H. Dallas,
 
1,2
 
 Barbara Varnum-Finney,
 
1 
 
Colleen Delaney,
 
1,2
 
 
 
Keizo Kato,
 
1
 
 and Irwin D. Bernstein
 
1,2
 
1
 
Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, WA 98109
 
2
 
Department of Pediatrics, University of Washington, Seattle, WA 98195
 
Notch signaling regulates multiple cell fate decisions by hematopoietic precursors. To 
address whether different amounts of Notch ligand influence lineage choices, we cultured 
murine bone marrow lin
 
 
 
Sca-1
 
 
 
c-kit
 
 
 
 cells with increasing densities of immobilized 
Delta1
 
ext-IgG
 
 consisting of the extracellular domain of Delta1 fused to the Fc domain of 
human IgG
 
1
 
. We found that relatively lower densities of Delta1
 
ext-IgG
 
 enhanced the 
generation of Sca-1
 
 
 
c-kit
 
 
 
 cells, Thy1
 
 
 
CD25
 
 
 
 early T cell precursors, and B220
 
 
 
CD43
 
 
 
/lo
 
 
cells that, when cocultured with OP9 stroma cells, differentiated into CD19
 
 
 
 early B cell 
precursors. Higher densities of Delta1
 
ext-IgG
 
 also enhanced the generation of Sca-1
 
 
 
c-kit
 
 
 
 
precursor cells and promoted the development of Thy1
 
 
 
CD25
 
 
 
 cells, but inhibited the 
development of B220
 
 
 
CD43
 
 
 
/lo
 
 cells. Analyses of further isolated precursor populations 
suggested that the enhanced generation of T and B cell precursors resulted from the effects 
on multipotent rather than lymphoid-committed precursors. The results demonstrate the 
density-dependent effects of Delta1 on fate decisions of hematopoietic precursors at 
multiple maturational stages and substantiate the previously unrecognized ability of Delta1 
to enhance the development of both early B and T precursor cells.
 
The detection of Notch receptors in hemato-
poietic precursors suggested a role for Notch
signaling in early hematopoietic development,
whereas the potential role of Notch in regulat-
ing the self-renewal of multipotent precursors
and in determining T versus B cell fates has
been demonstrated in both gain- and loss-of-
function studies (1–5). Studies using exogenous
cell-expressed or soluble Notch ligand forms
to activate endogenous Notch receptors have
also revealed the effects of Notch signaling on
the self-renewal of nonmutant hematopoietic
precursors (6, 7). Jagged1, Jagged2, Delta1,
and Delta4 have thus all been shown to affect
the differentiation of hematopoietic precur-
sors, including repopulating cells. In addition,
Delta1 and Delta4 have been shown to pro-
mote early T cell differentiation (6–12). The
expression of the different Notch ligands and
their receptors at different times and in a tis-
sue-specific manner raises the possibility of a
unique function for each ligand (13, 14).
However, the mechanisms by which specific
ligands induce different cellular fates remains
unclear.
We investigated whether quantitative dif-
ferences in the amount of Notch signaling in-
duced by different doses of the Notch ligand
Delta1 might account for these selective effects.
This is suggested by studies with 
 
Drosophila
 
 that
demonstrate how different functions of Notch
can require different threshold levels of signal-
ing. For example, half the wild-type level of
 
Notch
 
 gene dosage is insufficient to properly
specify the dorsoventral margin of a wing,
giving rise to the eponymous “notched wing”
phenotype; however, it does suffice for most
functions of Notch in the wild type (15, 16).
 
.
 
In vertebrates, a relative reduction in the level
of Notch1 in developing T cells can influence
their fate to the extent that cells with a single
copy of the Notch1 gene are less likely to be-
come 
 
  
 
 T cells than are wild-type cells (17).
In developing B cells, a relative reduction in
Notch2 results in diminished B1 B cells and a
marked reduction in marginal zone B cells (18).
The quantitative effects of Notch ligands have
also been demonstrated (a) in mice, where the
homozygous deletion of Jagged1 led to embry-
onic lethality though a partial phenotype resulted
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only in eye defects (19); and (b) in humans, where the haplo-
insufficiency of Jagged1 appears to be responsible for Alagille
syndrome, a pleiotropic disorder involving multiple organ
systems (20). We show that the Notch ligand Delta1 can en-
hance the generation of early T and B cell progenitors from
multipotent hematopoietic precursors depending on the den-
sity of the ligand. We demonstrate that higher densities of
Delta1 mainly promote the adoption of a T cell fate, whereas
relatively lower densities enhance the generation of early T-
and B-lymphoid precursors.
 
RESULTS AND DISCUSSION
 
To assess the effect of varying densities of immobilized
Delta1
 
ext-IgG
 
 on the induction of Notch signaling, we measured
the expression of the Notch target gene, 
 
Hes1
 
, in lin
 
 
 
Sca-
1
 
 
 
c-kit
 
 
 
 (LSK) marrow cells with a Hoechst 33342 dye efflux
profile of a “side population” enriched for stem cells (LSK-SP).
After culturing for 3 h on plates coated with increasing concen-
trations of Delta1
 
ext-IgG
 
 in the presence of murine stem cell fac-
tor (mSCF), human Flt-3 ligand (Flt3L), IL6, and IL11 (4GF),
 
Hes1
 
 mRNA expression was assessed using SYBR green quan-
titative RT-PCR. Compared with control cells cultured on
human IgG
 
1
 
, cells cultured with the ligand plated at 2.5 
 
 
 
g/ml
showed a 1.4 
 
 
 
 0.1-fold increase in 
 
Hes1
 
 expression, whereas
cells cultured with the ligand plated at 10 
 
 
 
g/ml showed a
2.6 
 
 
 
 0.2-fold increase (mean 
 
 
 
 SEM from four separate ex-
periments). This indicated an increased activation of Notch sig-
naling in a Delta1
 
ext-IgG
 
 dose-dependent manner.
Figure 1. Proliferation and differentiation of LSK cells during 
culture with various Delta1ext-IgG densities. (A) Total number of cells 
( ) generated from LSK cells after 14 d of incubation with Delta1ext-IgG 
plated at increasing concentrations. (B) Number of cells exhibiting an 
immature (Sca-1 c-Kit ;  ) or myeloid (Gr1  and/or F4/80 ;  ) pheno-
type. (C) Cells with an early T cell (Thy1 CD25 ;  ) or early lymphoid 
(B220  CD43 /lo;  ) phenotypes were determined based on cell count and 
FACS analysis. (D) The data shown represent the mean   SEM of three 
experiments. The numbers in the corners of the flow cytometry plots 
represent the percentage of gated events within that quadrant. 
JEM VOL. 201, May 2, 2005
 
1363
 
BRIEF DEFINITIVE REPORT
 
To investigate the effect of varying densities of Delta1
 
ext-IgG
 
on hematopoietic cell proliferation and differentiation, we
assessed the types and numbers of cells generated after cultur-
ing marrow-sorted LSK cells for 14 d with increasing densi-
ties of Delta1
 
ext-IgG
 
. We found a 10-fold greater generation of
cells in the presence of Delta1
 
ext-IgG
 
 plated at concentrations
of 
 
 
 
1.25 
 
 
 
g/ml compared with the number of cells gener-
ated with control IgG
 
1
 
 (Fig. 1 A). Additionally, a phenotypic
analysis revealed that the number of Sca-1
 
 
 
c-kit
 
 
 
 cells gen-
erated was significantly higher in cultures with densities es-
tablished by plating at 
 
 
 
2.5 
 
 
 
g/ml of Delta1
 
ext-IgG
 
 compared
with cultures with control IgG
 
1
 
 or lower densities of
Delta1
 
ext-IgG
 
 (
 
 
 
1.25 
 
 
 
g/ml). In contrast, the number of my-
eloid cells (Gr1
 
 
 
 and/or F4/80
 
 
 
) generated in cultures with
lower densities of Delta1
 
ext-IgG
 
 (
 
 
 
2.5 
 
 
 
g/ml) was comparable
with that in control IgG
 
1
 
 cultures, but was significantly re-
duced in cultures with densities of Delta1
 
ext-IgG
 
 established by
plating at 
 
 
 
5 
 
 
 
g/ml of Delta1
 
ext-IgG
 
 (Fig. 1, B and D).
In cultures with an increasing density of Delta1
 
ext-IgG
 
, we
found increased numbers of cells expressing Thy1 and
CD25, which is suggestive of early T cell differentiation
(Fig. 1 C). Compared with control IgG
 
1
 
, there was a 4-log
increase in the number of Thy1
 
 
 
CD25
 
 
 
 cells in cultures
with Delta1
 
ext-IgG
 
 plated at 
 
 
 
5 
 
 
 
g/ml. Furthermore, the
presence of T cell precursors was confirmed by quantitative
RT-PCR that revealed the expression of 
 
CD3
 
 
 
 and 
 
pre-T
 
 
 
mRNA at 28 d of culture in cells cultured on Delta1
 
ext-IgG
 
,
but not in control cultures (Fig. 2, A and B). 
Studies by us and others have previously reported that B
cell differentiation is inhibited in cultures with Delta1 (7, 11,
21). However, our previous studies tested immobilized
Delta1
 
ext-IgG
 
 plated only at a high concentration (10 
 
 
 
g/ml).
To determine whether a culture with lower densities of
Delta1
 
ext-IgG
 
 allowed for the generation of B lymphoid pre-
cursors, cultured LSK cells were also analyzed for the expres-
sion of the B cell–associated antigens B220, CD43, CD19,
and IgM. Cells expressing CD19 or IgM were not generated
in any culture conditions (unpublished data). However, the
Figure 2. Induction of pre-T  and CD3  expression is dependent 
on the density of Delta1ext-IgG. (A) CD3  and (B) pre-T  gene expressions 
by LSK cells after culture for 28 d with different densities of Delta1ext-IgG 
determined by quantitative RT-PCR. Data shown represent the ratio of 
gene expression compared with the housekeeping gene Rpl7.
Figure 3. T and B cell potential of Delta1ext-IgG–cultured 
B220 CD43 /lo or B220  populations. After the culture of LSK cells for 
21 d with different densities of Delta1ext-IgG, B220 CD43 /lo (A) or B220  
(B) cells were isolated by FACS and transferred to cultures containing OP9 
stromal cells or 10  g/ml of Delta1ext-IgG. (C) Early B (B220 CD19 ) or 
early T (Thy1 CD25 ) cell phenotypes were determined with FACS analysis. 
The numbers in the corners of the flow cytometry plots represent the 
percentage of gated events within that quadrant.EFFECT OF DELTA1 DENSITY ON HEMATOPOIESIS | Dallas et al. 1364
number of B220 CD43 /lo cells increased substantially in cul-
tures containing lower densities of Delta1ext-IgG (0.6–1.25  g/
ml) compared with control IgG1 or higher density Delta1ext-IgG-
containing cultures ( 2.5  g/ml; Fig. 1, C and D).
To investigate the B cell potential of cells generated with
the Notch ligand, LSK cells cultured for 21 d with varying
densities of Delta1ext-IgG were transferred onto an OP9 stro-
mal cell culture containing mSCF, Flt3L, and IL7. These
cells were then analyzed by FACS analysis at 1 and 2 wk, re-
vealing CD19  cells only in cultures containing cells previ-
ously incubated with low densities of immobilized Delta1ext-IgG
(0.6  g/ml or 1.25  g/ml; unpublished data). To deter-
mine whether the CD19  cells generated by coculture with
OP9 stromal cells were obtained from the B220 CD43 /lo
population, we also isolated B220 CD43 /lo and B220 
cells from the cultured LSK cells by FACS before transfer-
ring them onto OP9 stromal cell cultures. After 7 d, B220 
CD19  cells were observed only in cultures initiated with
B220 CD43 /lo cells obtained from LSK cells that had been
cultured in the presence of Delta1ext-IgG plated at 1.25  g/ml
(Fig. 3 A). CD19  cells were not generated after the culture
of the sorted B220  cells on OP9 cells (Fig. 3 B).
In addition, the T cell potential of the sorted B220 
CD43 /lo and B220  populations generated after the culture
of LSK cells with different densities of Delta1ext-IgG was also
examined by transferring these sorted cells into wells con-
taining Delta1ext-IgG plated at 10  g/ml, along with 4GF and
IL7. After 7 d of culture, the sorted B220 CD43 /lo cells
failed to proliferate (unpublished data). However, the sorted
B220  cells from wells established with Delta1ext-IgG plated at
 2.5  g/ml did proliferate and generate Thy1 CD25  cells
(Fig. 3 C). These results suggest that only the B220  cells re-
tained the potential to differentiate along the T cell lineage,
whereas the B220 CD43 /lo cells were limited to early
B cell differentiation. The failure of these B220 CD43  lo
cells to differentiate towards the T cell lineage when cul-
tured with relatively higher Delta1ext-IgG densities further
suggests that these cells were committed to B cell differentia-
tion. This finding raises the question of whether the previ-
ously demonstrated thymic repopulating ability of B220 
cell results from the B220  subset that expresses higher levels
of CD43 (22).
To identify the multipotent or committed precursors that
are affected by Notch signaling, we isolated subpopulations
of marrow LSK cells, including (a) LSK-SP cells that are en-
riched for long-term repopulating stem cells (23); (b) LSK
cells that express the Flt3 receptor and are enriched for
short-term repopulating stem cells (LSK-Flt3 ; reference
24); and (c) lin Sca-1loc-kitloThy1 /loIL7  cells that are en-
riched for common lymphoid progenitors (CLPs; reference
25). Similar to LSK cells, LSK-SP cells cultured with lower
densities of Delta1ext-IgG generated increased numbers of
Thy1 CD25  early T cell precursors and B220 CD43 /lo
early B cell precursors, as well as Gr-1  and/or F4/80  my-
eloid cells. Furthermore, as with LSK cells, LSK-SP cells
cultured with densities of ligand generated fewer numbers of
B220 CD43  lo and Gr-1  and/or F4/80  cells, but in-
creased numbers of Thy1 CD25  cells compared with LSK-
SP incubated with lower densities of Delta1ext-IgG (Fig. 4 A).
Results obtained with LSK-Flt3  cells were similar to those
obtained with LSK-SP cells, except that fewer B cells and
myeloid cells were generated at lower ligand densities (Fig. 4
B). This is possibly because the LSK-Flt3  cells possess less
potential for proliferation and self-renewal than the less ma-
ture LSK-SP cells. In contrast, CLPs cultured with or with-
out ligand did not generate significantly increased numbers
of any type of cells, but primarily differentiated into
B220 CD43  lo cells after 3 d of culture with or without
ligand. CLPs cultured with higher densities of Delta1ext-IgG
did, however, generate Thy1  CD25  cells, although it is
not clear whether these cells were derived from uncommit-
ted or committed T-lymphoid precursors (Fig. 4 C).
In this study, we have shown that ligand-induced Notch
activation in multipotent hematopoietic precursor cells regu-
lates lineage expression in a density-dependent manner. Our
data suggest that the enhanced formation of B and T precur-
sors occurs in the presence of lower densities of Delta1ext-IgG
because of the effects on multipotent precursors. In addition,
higher densities of ligand lead mainly to T cell differentiation
because of the inhibition of early B cell and myeloid differ-
entiation by multipotent precursors and the promotion of
T cell differentiation by lymphoid committed precursors.
These results represent the first evidence that a single Notch
ligand can enhance the development of cells that adopt ei-
ther a B or a T cell fate.
Previous studies of cell fate outcomes induced by Delta1
have used cell-expressed ligands and were thus unable to ad-
dress quantitative differences in ligand expression (11, 21,
26). However, our studies suggest that lower densities of
Delta1 induce Notch signaling enough to increase precursor
cell numbers that then assume the default B cell pathway be-
cause the induced Notch signaling was insufficient to further
promote development along the T cell pathway and inhibit
B cell, as well as myeloid cell, development. Similar differen-
Figure 4. Differentiation of LSK-SP, LSK-Flt3 , and CLP cells dur-
ing culture with various Delta1ext-IgG densities. LSK-SP, LSK-Flt3 , and 
CLP cells isolated by FACS from marrow were incubated with Delta1ext-IgG 
plated at increasing concentrations. LSK-SP (A) and LSK-Flt3  (B) cells 
were incubated for 14 d and CLP (C) cells were incubated for 3 d. Numbers 
of generated myeloid (Gr1  and/or F4/80 ;  ), early T cell (Thy1 CD25 ; 
 ), or early lymphoid (B220  CD43 /lo;  ) cells were determined based on 
cell count and FACS analysis.JEM VOL. 201, May 2, 2005 1365
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tial cell fate choices have been seen in studies comparing
Notch signaling induced by Delta versus Jagged (21, 26, 27).
The latter differences may result from distinct receptors be-
ing induced by the different ligands or they may reflect de-
creased signal intensity from one or the other ligand. This is
supported by studies showing that Notch signaling induced
by Jagged may result in decreased signal intensity in the pres-
ence of Fringe, where Jagged1 activates Notch2 but not
Notch1 (28). Thus, Notch signaling induced by Jagged1
would expectedly be lower than that induced by Delta1 be-
cause Delta1 activates both Notch1 and Notch2. The find-
ing that different concentrations of a single Notch ligand
leads to differential cell fate outcomes raises the possibility
that multiple Notch ligand–receptor combinations simply
regulate Notch signaling quantitatively to affect cell fates.
However, qualitative differences between Notch1- and
Notch2-induced signaling may also play a role.
It remains unclear how quantitative differences in Notch
ligand density leads to different cell fate outcomes. It is possi-
ble that Notch signaling must exceed specific thresholds in
order to instruct particular cell fates. For example, different
Hes1 expression levels induced in individual cells might dif-
ferentially affect downstream genes that have different thresh-
olds for Hes1 regulation. Other Notch target genes, such as
Hes5 or Herp2, may also be differentially induced and serve
in concert to regulate differentiation programs. 
The variable densities of individual Notch ligands in dif-
ferent regions of marrow or thymic stroma, together with
the expression of Notch ligands by developing hematopoie-
tic cells that may activate Notch signaling in adjacent cells,
suggest the potential importance of ligand density in vivo. In
addition to the implications of our findings for growing a va-
riety of stem cell types in vitro for therapeutic purposes, the
investigation of physiologic stimuli that might induce varia-
tions of Notch ligand expression could provide a novel ave-
nue for manipulating cell development in vivo.
MATERIALS AND METHODS
Generation of Delta1ext-IgG. Delta1ext-IgG were prepared as previously de-
scribed (29). Reagent grade purified human IgG1 was purchased from
Sigma-Aldrich.
Immobilization of varying Delta1ext-IgG densities. The ligand was im-
mobilized on the plastic surface of the culture vessel as previously described
(7). The direct relationship of the plated ligand and the bound ligand con-
centration was demonstrated by ELISA with an HRP-conjugated Fc
specific anti–human-IgG antibody (Sigma-Aldrich) for the detection of
Delta1ext-IgG, which demonstrated a linear relationship between the increas-
ing concentration of plated ligand and the increased amounts of bound
ligand (R2   0.73; P   0.007).
Cell isolation and immunofluorescence studies. The immunopheno-
type was analyzed by five-color flow cytometery using an LSR cytometer
(Becton Dickinson). Antibodies were purchased from BD Biosciences, un-
less otherwise noted. Cultured cells were prepared as previously described
(6) and stained with the following: (a) FITC-conjugated monoclonal anti-
bodies against Thy1, Gr1, and B220; (b) PE-conjugated monoclonal anti-
bodies against CD25, CD43, CD19, CD127, CD135, and F4/80 (Caltag);
and (c) biotinylated antibodies against Sca-1, B220, and IgM secondarily
stained with streptavidin-PE-Cy7, and APC monoclonal antibodies against
c-kit. LSK cells were cells with a high expression of Sca-1 and c-Kit on
bone marrow depleted from the following lineages: CD2, CD3, CD8a,
CD5, CD11b, B220, GR-1, and TER-119. LSK cells were obtained using
FACS on a Vantage Cell Sorter (Becton Dickinson) as previously described
(6). LSK-SP cells were isolated with the addition of Hoechst 33342 dye
(Calbiochem) and gating was as described previously (23). LSK-Flt3  cells
were isolated from lineage-depleted bone marrow using FITC-conjugated
anti–Sca-1, PE-conjugated anti-CD135 (Flk-2/Flt3), and APC-conjugated
anti–c-kit as described previously (24). CLP was sorted using lineage-
depleted bone marrow stained with FITC-conjugated anti-Thy1, PE-con-
jugated anti–CD-127, biotinylated anti–Sca-1, and the APC-conjugated
anti–c-kit, and gated as described previously (25). For the isolation of
B220 CD43 /lo and B220  cells, cultured cells were stained with FITC-
conjugated anti-CD43 antibody and PE-conjugated anti-B220 antibody
and isolated by FACS. Sorted cells were  95% pure, as determined by a
postsort analysis. In all cases, cells were stained with DAPI or propidium io-
dide (Sigma-Aldrich) to gate for dead cells.
Hematopoietic cell culture. C57BL/6J (Ly5.2) mice (8–10 wk old) ob-
tained from the Jackson Laboratory were maintained and bred at the Fred
Hutchinson Cancer Research Center. 103 LSK cells were cultured with im-
mobilized ligand in IMDM supplemented with 20% FBS and 4GF (100 ng/
ml each of mSCF, human Flt3L, and human IL6, and 10 ng/ml human
IL11; PeproTech) as previously described (7). To test for B cell differentia-
tion, OP9 stromal cell monolayers were prepared 2 d prior by plating 2.5  
104 OP9 cells/well in a 24-well tissue culture–treated plate (Costar) in
 MEM with 20% FBS. Cultured LSK cells were then plated onto an OP9
stromal monolayer in  MEM containing 20% FBS, penicillin, and 10 ng/
ml Flt3L, mSCF, and human IL7 (PeproTech). Supplemental media were
added every fourth day.
RNA isolation and real-time RT-PCR. The total RNA was extracted
with an Absolutely RNA RT-PCR Miniprep Kit (Stratagene) according to
the manufacturer’s instructions. Single strand cDNA was synthesized with
oligo-dT primer using reagents provided in the ThermoScript RT-PCR Sys-
tem (Invitrogen) for 45 min at 50 C. Quantitative PCR was performed using
SYBR Green PCR Master Mix on an ABI PRISM 7700 sequence detection
system (Applied Biosystems) in the following conditions: an initial denatur-
ation step at 94 C for 10 min followed by 40 cycles of 95 C for 30 s, 60 C for
30 s, and 72 C for 45 s. Transcript quantification was performed in duplicate
for every sample, and each gene expression was normalized to the housekeep-
ing gene Ribosomal protein L7 (Rpl7) expression. Primers were designed
from sequences of different exons for each gene to prevent the amplification
of genomic DNA as follows: Hes1 forward primer, 5 -GGCCTCTGAGC-
ACAGAAAGT-3 ;  Hes1 reverse primer, 5 -GTGTTAACGCCCTCAC-
ACG-3 ; pre-T  forward primer, 5 -TGGGAGGCAGACTAGCAGAG-
3 ; pre-T  reverse primer, 5 -CCCATAGGTGAAGGCGTCTA-3 ; CD3 
forward primer, 5 -GTCCGCCATCTTGGTAGAGA-3 ;  CD3  reverse
primer, 5 -TTGAGGCTGGTGTGTAGCAG-3 ; Rpl7 forward primer, 5 -
GAAGCTCATCTATGAGAAGGC-3 ; and Rpl7 reverse primer, 5 -AAG-
ACGAAGGAGCTGCAGAAC-3 .
Statistical methods. Statistical significances were determined using analy-
sis of variance with Bonferroni posttest.
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